These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 21569199)
21. Prognostic utility of apoptosis index, Ki-67 and survivin expression in dogs with nasal carcinoma treated with orthovoltage radiation therapy. Fu DR; Kato D; Watabe A; Endo Y; Kadosawa T J Vet Med Sci; 2014 Nov; 76(11):1505-12. PubMed ID: 25452259 [TBL] [Abstract][Full Text] [Related]
22. Prospective evaluation of a 5 × 4 Gy prescription for palliation of canine nasal tumors. Tan-Coleman B; Lyons J; Lewis C; Rosenberg M; Ruiz A Vet Radiol Ultrasound; 2013; 54(1):89-92. PubMed ID: 23002718 [TBL] [Abstract][Full Text] [Related]
23. Use of an image-guided robotic radiosurgery system for the treatment of canine nonlymphomatous nasal tumors. Glasser SA; Charney S; Dervisis NG; Witten MR; Ettinger S; Berg J; Joseph R J Am Anim Hosp Assoc; 2014; 50(2):96-104. PubMed ID: 24446402 [TBL] [Abstract][Full Text] [Related]
24. Retrospective review of 50 canine nasal tumours evaluated by low-field magnetic resonance imaging. Avner A; Dobson JM; Sales JI; Herrtage ME J Small Anim Pract; 2008 May; 49(5):233-9. PubMed ID: 18373540 [TBL] [Abstract][Full Text] [Related]
25. Radiological assessment of severity of canine nasal tumours and relationship with survival. Morris JS; Dunn KJ; Dobson JM; White RA J Small Anim Pract; 1996 Jan; 37(1):1-6. PubMed ID: 8642793 [TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of midline shift of the olfactory or frontal lobes of the brain in canine nasal carcinomas treated by palliative radiotherapy: a pilot study. Wada Y; Noguchi S; Sasaki H; Taketomi A; Hamakawa M; Shimamura S; Shimada T J Vet Med Sci; 2018 Nov; 80(11):1724-1727. PubMed ID: 30305466 [TBL] [Abstract][Full Text] [Related]
27. Combination of radiation therapy and firocoxib for the treatment of canine nasal carcinoma. Cancedda S; Sabattini S; Bettini G; Leone VF; Laganga P; Rossi F; Terragni R; Gnudi G; Vignoli M Vet Radiol Ultrasound; 2015; 56(3):335-43. PubMed ID: 25703137 [TBL] [Abstract][Full Text] [Related]
28. [Hypofractionated radiation therapy for the treatment of malignant melanoma and squamous cell carcinoma in dogs and cats]. Kinzel S; Hein S; Stopinski T; Koch J; Buecker A; Treusacher HP; Schmachtenberg A; Jansen T; Eble M; Küpper W Berl Munch Tierarztl Wochenschr; 2003; 116(3-4):134-8. PubMed ID: 12680280 [TBL] [Abstract][Full Text] [Related]
29. COX-2 expression in canine anal sac adenocarcinomas and in non-neoplastic canine anal sacs. Knudsen CS; Williams A; Brearley MJ; Demetriou JL Vet J; 2013 Sep; 197(3):782-7. PubMed ID: 23778258 [TBL] [Abstract][Full Text] [Related]
30. Long-term outcome of 56 dogs with nasal tumours treated with four doses of radiation at intervals of seven days. Mellanby RJ; Stevenson RK; Herrtage ME; White RA; Dobson JM Vet Rec; 2002 Aug; 151(9):253-7. PubMed ID: 12233825 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of outcomes and radiation complications in 65 cats with nasal tumours treated with palliative hypofractionated radiotherapy. Fujiwara-Igarashi A; Fujimori T; Oka M; Nishimura Y; Hamamoto Y; Kazato Y; Sawada H; Yayoshi N; Hasegawa D; Fujita M Vet J; 2014 Dec; 202(3):455-61. PubMed ID: 25312719 [TBL] [Abstract][Full Text] [Related]
32. Prognostic status of p53 gene mutation in canine mammary carcinoma. Wakui S; Muto T; Yokoo K; Yokoo R; Takahashi H; Masaoka T; Hano H; Furusato M Anticancer Res; 2001; 21(1B):611-6. PubMed ID: 11299814 [TBL] [Abstract][Full Text] [Related]
33. Reirradiation of canine nasal carcinomas treated with coarsely fractionated radiation protocols: 37 cases. Gieger T; Siegel S; Rosen K; Jackson D; Ware K; Kiselow M; Shiomitsu K J Am Anim Hosp Assoc; 2013; 49(5):318-24. PubMed ID: 23861260 [TBL] [Abstract][Full Text] [Related]
34. Late presentation of canine nasal tumours in a UK referral hospital and treatment outcomes. Mason SL; Maddox TW; Lillis SM; Blackwood L J Small Anim Pract; 2013 Jul; 54(7):347-53. PubMed ID: 23718867 [TBL] [Abstract][Full Text] [Related]
35. Prognostic factors and survival after radiotherapy for intranasal neoplasms in dogs: 70 cases (1974-1985). Evans SM; Goldschmidt M; McKee LJ; Harvey CE J Am Vet Med Assoc; 1989 May; 194(10):1460-3. PubMed ID: 2722643 [TBL] [Abstract][Full Text] [Related]
36. Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal type. Shim SJ; Yang WI; Shin E; Koom WS; Kim YB; Cho JH; Suh CO; Kim JH; Kim GE Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):31-8. PubMed ID: 17049184 [TBL] [Abstract][Full Text] [Related]
37. An immunohistochemical study of the inflammatory infiltrate associated with nasal carcinoma in dogs and cats. Vanherberghen M; Day MJ; Delvaux F; Gabriel A; Clercx C; Peeters D J Comp Pathol; 2009 Jul; 141(1):17-26. PubMed ID: 19362315 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of tumor volume reduction of nasal carcinomas versus sarcomas in dogs treated with definitive fractionated megavoltage radiation: 15 cases (2010-2016). Morgan MJ; Lurie DM; Villamil AJ BMC Res Notes; 2018 Jan; 11(1):70. PubMed ID: 29361976 [TBL] [Abstract][Full Text] [Related]
39. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix. Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199 [TBL] [Abstract][Full Text] [Related]
40. Retrospective study of canine nasal tumor treated with hypofractionated radiotherapy. Maruo T; Shida T; Fukuyama Y; Hosaka S; Noda M; Ito T; Sugiyama H; Ishikawa T; Madarame H J Vet Med Sci; 2011 Feb; 73(2):193-7. PubMed ID: 20938105 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]